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Abstract: The appropriate display of social behaviors is essential for the well-being, reproductive
success and survival of an individual. Deficits in social behavior are associated with impaired
N-methyl-D-aspartate (NMDA) receptor-mediated neurotransmission. In this review, we describe
recent studies using genetically modified mice and pharmacological approaches which link the
impaired functioning of the NMDA receptors, especially of the receptor subunits GluN1, GluN2A and
GluN2B, to abnormal social behavior. This abnormal social behavior is expressed as impaired social
interaction and communication, deficits in social memory, deficits in sexual and maternal behavior, as
well as abnormal or heightened aggression. We also describe the positive effects of pharmacological
stimulation of the NMDA receptors on these social deficits. Indeed, pharmacological stimulation of the
glycine-binding site either by direct stimulation or by elevating the synaptic glycine levels represents
a promising strategy for the normalization of genetically-induced, pharmacologically-induced or
innate deficits in social behavior. We emphasize on the importance of future studies investigating
the role of subunit-selective NMDA receptor ligands on different types of social behavior to provide
a better understanding of the underlying mechanisms, which might support the development of
selective tools for the optimized treatment of disorders associated with social deficits.
Keywords: NMDAR agonists; NMDAR antagonists; social investigation; ultrasonic vocalizations;
social recognition; inter-male aggression; mating behavior; maternal care; maternal aggression
1. Introduction
The majority of the excitatory neurotransmission in the mammalian central nervous system (CNS) is
mediated by L-glutamate, which activates both presynaptic and postsynaptic ionotropic and metabotropic
receptors (iGluRs and mGluRs). iGluRs are ligand-gated cation channels and can be divided into
three classes: the α-amino-3-hydroxy-5-methyl-4-isoxasolepropionic acid (AMPA) receptors, kainate
receptors, and N-methyl-D-aspartate (NMDA) receptors [1]. The NMDA receptors are named after the
pharmacological agonist to whom they selectively respond and they function as ligand-gated channels.
In addition to L-glutamate, NMDA receptors require the binding of a co-agonist, glycine or D-serine,
to allow activation of the receptor, which then leads to the opening of a non-selective ion channel that
allows the influx of Na+ and Ca2+ into the cell and the efflux of K+ out of the cell [2]. Because of their
additional property of voltage-gating, the NMDA receptors function as coincidence-detectors. At resting
membrane potentials, a hydrated Mg2+ binds to a site within the channel and inactivates the NMDA
receptor. L-glutamate can only activate the receptor when the membrane is sufficiently depolarized
to relieve this Mg2+ blockade. Therefore, the likelihood that L-glutamate leads to channel opening is
dependent on the activation of AMPA receptors and membrane depolarization [3].
The NMDA receptors are heteromeric complexes formed of four constituent polypeptides, which
arrange to form the ion-conductive pore [4–7]. Most NMDA receptors contain two obligatory GluN1
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subunits (also called NR1), which create the ligand binding domain for glycine and D-serine and two
GluN2 (also called NR2) subunits, which create the ligand binding domain for L-glutamate. The GluN2
subunits can be of four different types: GluN2A, GluN2B, GluN2C and GluN2D and the expression of
these specific GluN2 subunits depends on the developmental age and brain region. As such, GluN2B
and GluN2D subunits predominate in the fetal brain and generally decline throughout development,
whereas the expression of GluN2A subunits increases after birth and predominates over GluN2B in the
olfactory bulb, cortex, hippocampus and cerebellum by postnatal days 14–21 in rats and mice [8–12].
In the mature brain, GluN2C is highly expressed in the cerebellum, whereas GluN2D is highly expressed
in subcortical regions and the brainstem. GluN1 and GluN2A are abundantly expressed in virtually
all regions of the adult brain [8,13,14], including brain regions involved in social behavior, such as
the olfactory bulbs, medial prefrontal cortex, amygdala, striatum, hippocampus, nucleus accumbens,
septum and hypothalamus (reviewed in [15,16]). Mature NMDA receptors can be diheterotetrameric
(i.e., GluN1/GluN2A or GluN1/GluN2B) and triheterotetrameric (i.e., GluN1/GluN2A/GluN2B) and
their function is influenced by the diversity and the combination of their subunits (reviewed in [3,17]).
Most cortical, amygdalar and hippocampal NMDA receptors are diheterotetrameric GluN1/GluN2A or
GluN1/GluN2B receptors or triheterotetrameric GluN1/GluN2A/GluN2B receptors [13,18,19]. While the
GluN2B-containing diheterotetrameric NMDA receptors have a preferential extra-synaptic localization
and promote pro-apoptotic and excitotoxic processes, the GluN2A-containing NMDA receptors are
predominantly synaptically-localized and may enhance the inhibitory drive of parvalbumin-expressing
GABAergic neurons, while avoiding neurotoxic consequences associated with excessive stimulation of
extra-synaptic GluN2B-containing receptors [4,19]. Although both excitatory and inhibitory neurons
express high levels of GluN2A receptors, the synaptic GluR2A-containing NMDA receptors are present
in a much higher density in inhibitory neurons [1,3]. It is estimated that GluN2A-containing NMDA
receptors account for about 68% of synaptic currents and only about 27% of extra-synaptic currents in
the mature forebrain, whereas the rest is accounted for by GluN2B-containing receptors [20]. It was also
suggested that D-serine may be the preferred co-agonist in synaptically-located NMDA receptors, whereas
glycine may be the preferred co-agonist in extra-synaptic NMDA receptors [21]. A regulatory GluN3 (also
called NR3) subunit may also be present in the receptor complex, particularly during development [22].
The appropriate display of social behavior is critical for the well-being, reproductive success and
survival of an individual as it allows for group living and successful interaction with other members of
the species, obtaining food and avoiding predation. Social behavior includes all kind of behaviors
that bring individuals together, i.e., social interaction and communication, reproductive and parental
behavior, as well as all forms of aggressive behavior [23]. The importance of social behavior is also
suggested by the high number of psychiatric disorders associated with social deficits, including social
anxiety disorder [24], autism spectrum disorders [25], depression [26], schizophrenia [26], Alzheimer’s
disease [26], alcohol use disorder [27] and fragile X syndrome [28], among others.
In this review we will describe the involvement of the NMDA receptor-mediated neurotransmission
in regulating social behavior and summarize some of the strategies aimed at facilitating NMDA receptor
function, which were shown to improve deficits in several aspects of social behavior in rodents.
2. Role of the NMDA Receptors in Social Interaction
Social interactions are complex behaviors which require multiple cognitive processes and
evaluation of social stimuli. A key aspect of social interaction is the motivation of an individual to
initiate and respond to another individual. Social interaction is thought to produce a rewarding effect
which reinforces and promotes approach behaviors [29,30]. The assessment of social interaction in
rodents is based on their preference to spend time with another conspecific rather than remaining
alone or to investigate social rather than non-social stimuli, i.e., objects, toys, etc. [31–33]. Rodents with
impaired social behavior show decreased interaction or investigation of conspecifics or decreased time
spent in a chamber containing an enclosed conspecific in tests such as the social interaction test, social
preference test and the three-chambered social approach test (reviewed in [34]).
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2.1. Genetic Models of Impaired NMDA Receptor Functioning; Effects on Social Interaction
Several studies using genetically modified mice demonstrated the importance of NMDA
receptor-mediated neurotransmission in the regulation of social interaction in rodents (Table 1).
As such, mice expressing only 5% of normal levels of the essential NMDA receptor GluN1 subunit
(NR1(neo−/−) mice) show deficits in social interaction when housed with wild-type littermates, i.e.,
remain physically distant while wild-type littermates sleep piled in a nest [35], initiate and maintain less
social interactions [35–37], avoid social interactions with littermates in the social interaction test [35] and
spend less time in the social compartment of the three-chambered social approach test [37]. Similarly,
knock-out mice with loss of GluN1 subunit in parvalbumin-containing GABAergic interneurons
during development also show reduced social motivation and impaired social interaction [38,39].
Belforte et al. [40] have demonstrated deficits in social interaction in mice in which the GluN1
subunit was selectively eliminated in 40–50% of cortical and hippocampal GABAergic interneurons in
early postnatal development, but not in the post-adolescent period, suggesting that early postnatal
inhibition of the NMDA receptor activity in corticolimbic GABAergic interneurons contributes to the
development of social deficits. However, Jacobs and Tsien [41] demonstrated that forebrain-specific
GluN1-containing NMDA receptors modulate social motivation independent of neuronal development.
As such, profound deficits in social motivation and social investigation were found in adult mice with
inducible forebrain-specific deletion of GluN1 subunits prior to sociability testing [41]. A similarly
impaired social behavior has been observed in Grin1D481N mice, a genetic model of chronic and
developmentally diminished NMDA receptor glycine site occupancy. These mice have a fivefold
decrease in NMDA receptor glycine affinity due to a point mutation in the GluN1 glycine binding
site [42] and show impaired social investigation in the three-chambered social approach test [43].
Impaired social investigation has also been described in serine racemase knock-out mice [44], which
show an impaired NMDA receptor function due to a 90% reduction in cortical D-serine, an endogenous
co-agonist acting on the NMDA receptor glycine-binding site, whose availability is dependent on the
activity of the enzyme serine racemase [45].
2.2. Effects of the NMDA Receptor Antagonists on Social Interaction
Pharmacological studies also revealed social interaction deficits after administration of several types
of NMDA receptor antagonists (Table 2). The NMDA receptor antagonists can be categorised in four
classes: competitive antagonists bind to and block the glutamate binding site, glycine antagonists block
the glycine binding site, non-competitive antagonists block the allosteric binding sites and un-competitive
antagonists block the ion channel by binding to a site within it. Most of the studies used un-competitive
antagonists, such as 5R,10S-(+)-5-methyl-10,11-dihydro-5H- dibenzo[a,d]cyclohepten-5,10-imine
hydrogen maleate (MK-801, also known as dizocilpine), phencyclidine (PCP) and ketamine, to induce
social interaction deficits and to mimic the negative symptoms of schizophrenia. As such, MK-801
decreased social interaction following both acute [46–54] and sub-chronic [55] treatment in adult rats
and mice. Similarly, acute [56,57], sub-chronic [58–61] and chronic [62] administration of PCP decreased
social interaction in adult rats and mice. Impairments in social interaction were also described in adult
rats treated with PCP on postnatal days 7, 9 and 11 [63] and during adolescence on postnatal days
50 and 51 [64], suggesting that inhibition of NMDA receptor activity both during development and
adulthood induces long-lasting changes in social behavior. Long-lasting social interaction deficits were
also described by Qiao et al. [65] in mice during withdrawal from chronic PCP treatment (for a review
see [66]). Similar to MK-801 and PCP, ketamine was shown to decrease social interaction following both
acute [67–70] and sub-chronic [71–73] administration in rats and mice.
Interestingly, studies using acute administration of GluN2A and GluN2B subtype-selective
competitive antagonists revealed age-dependent differences in the social interaction test. As such,
adolescent rats required higher doses of MK-801 and of the GluN2B-preferring antagonist ifenprodil
to reduce social interactions than adults did, whereas an opposite age effect was observed after
administration of {NVP-AAM o77; P-[[[(15)-1-(4-Bromophenyl)ethyl]amino](1,2,3,4-tetrahydro-2,3-
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dioxo-5-qyuinoxalinyl)methyl]phosphoric acid tetrasodium salt} (PEAQX), a GluN2A-preferring
antagonist [4,49]. These results suggest that social interaction in adolescence is more sensitive to
GluN2A-selective antagonism, whereas social interaction in adulthood is more sensitive to NMDA- and
GluN2B-selective receptor antagonism and indicate that these differences may be related to different
subunit expression patterns during development. As such, GluN2B subunits predominate in the fetal
brain and generally decline throughout development, whereas the expression of GluN2A subunits
increases after birth and predominates over GluN2B in the cortex, hippocampus and cerebellum
by postnatal days 14-21 in rats and mice [8–12]. Interestingly, the NMDA receptor antagonists
1-amino-3,5-dimethyladamantane hydrochloride (memantine) reduced the social interaction deficits
in mice prenatally treated with citalopram [74]. These effects of memantine, however, are not so
surprising given that prenatal citalopram treatment increased GluN1 expression in the striatum [74].
Similarly, memantine reduced the social interaction deficits in IRSp53 knock-out mice [75] which show
increased NMDA receptor function in the hippocampus [76], suggesting that deviations in NMDA
receptor functioning in either direction (see also Section 2.3.) lead to deficits in social interaction and
that correcting this deviation has beneficial effects.
2.3. Effects of the NMDA Receptor Agonists on Social Interaction
Studies using genetically modified mice and pharmacological approaches indicate that a decreased
NMDA receptor function is associated with social interaction deficits (Tables 1 and 2). Since direct
stimulation of the L-glutamate-binding site of the NMDA receptors can produce excitotoxic neuronal
death [77,78], the enhancement of the NMDA receptor function by targeting the glycine-binding site may
be more beneficial. There are two feasible ways of stimulating the glycine-binding site of the NMDA
receptor, i.e., by direct stimulation of the glycine-binding site and by elevating the synaptic glycine levels.
Agonists of the glycine-binding site of the NMDA receptors include glycine, D-serine, D-cycloserine,
GLYX-13, vinyl glycine and a series of 3-acylamino-2-aminopropionic acid derivatives [79–81].
The positive effects of D-serine, a full agonist of the glycine-binding site of the NMDA receptors,
have been demonstrated in inbred autistic Balb/c mice that show impaired social interaction [82–85]
and heightened behavioral sensitivity to MK-801 [86–88] (Table 2). As such, acute administration
of D-serine improved social investigation in Balb/c mice and increased the time spent in the social
compartment of the three-chambered social approach test [89]. D-serine also improved the social
investigation deficits of Grin1D481N mice, which show decreased NMDA receptor glycine affinity
due to a point mutation in the GluN1 glycine binding site [42] and impaired social investigation [46].
Interestingly, long-term increases in D-serine through a genetic inactivation of its catabolic enzyme
D-amino acid oxidase (DAO) was shown to reverse the social interaction deficits of Grin1D481N mice,
without altering social investigation in wild-type mice [90], suggesting that overstimulation of the
glycine-binding site of the NMDA receptors does not negatively affect social interaction. Furthermore,
Nagai et al. [91] have shown that D-serine ameliorates social interaction deficits by potentiating the
NMDA receptor activity. As such, mice treated with polyriboinosinic-polyribocytidilic acid (polyI:C;
a synthetic analog that elicits viral-like immune responses) during early postnatal development show
social interaction deficits which could be improved by D-serine treatment in adulthood, an effect which
was antagonized by pretreatment with the un-competitive NMDA-receptor antagonist MK-801 [91].
D-cycloserine, a partial agonist of the glycine-binding site of NMDA receptors was also effective
in improving the social interaction deficits observed in autistic Balb/c mice [85,92–94], in autistic BTBR
T+tf/J mice [95] and in autistic Shank2 knock-out mice, which show diminished expression of the Shank2
postsynaptic scaffolding protein and decreased function of the GluN2A- and GluN2B-containing
NMDA receptors in the hippocampus [96]. Acute administration of D-cycloserine also normalized
the autistic-like alterations caused by prenatal exposure to the anticonvulsant drug valproic acid in
rats [97,98] and improved the social interaction deficits induced by postnatal PCP treatment in mice,
without altering social investigation in control mice [99].
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Another way to stimulate the glycine-binding site of the NMDA receptors is by elevating the
synaptic glycine levels. This can be achieved by inhibiting the glycine transporter 1 (GlyT1), which
removes glycine from the synaptic cleft and is closely associated with the NMDA receptor [100].
Competitive GlyT1 inhibitors such as sarcosine (N-methylglycine), N[3-(4′-flurophenyl)-3-(4′-
phenylphenoxy) propyl]sarcosine (NFPS, a sarcosine analogue) and 3-chloro-N-{(S)-[3-(1-ethyl-1H-
pyrazol-4-yl)phenyl][(2S)-piperidin-2-yl]methyl}-4-(trifluoromethyl)pyridine-2-carboxamide
(TASP0315003) are, therefore, expected to increase the NMDA receptor function by indirectly
activating the glycine-binding site. Increasing the NMDA receptor function by both acute and
sub-chronic administration of TASP0315003 was shown to reverse PCP-induced deficits in
social interaction, without altering social investigation in control mice [101]. Another selective
high-affinity competitive GlyT1 inhibitor, 2,4-dichloro-N-((4-(cyclopropylmethyl)-1-(ethyl
sulfonyl)piperidin-4- yl)methyl)benzamide (VU0410120), improved the social interaction deficits
of autistic Balb/c mice [102], further demonstrating the efficacy of GlyT1 inhibitors.
3. Role of the NMDA Receptors in Social Communication
Many vertebrates use species-specific vocalizations to communicate information regarding
identity, group status, mood, environmental conditions (presence of predators or location of food)
and to facilitate mother-offspring interactions. Rats emit three types of ultrasonic vocalizations (USV)
depending on age, environmental conditions and affective state. As such, 50 kHz USV are emitted
under non-aversive conditions, such as juvenile play [103,104], sexual behavior [105] and during
manual tactile stimulation (“tickling”) by experimenters [106,107]. These 50 kHz USV are thought to
reflect a positive affective state. Rats can also emit 22 kHz USV in aversive situations, such as exposure
to predators [108], inescapable pain induced by foot shocks [109], in response to startling noises [110]
and during social defeat and inter-male aggression [111]. These 22 kHz USV are thought to reflect a
negative affective state. Unlike rats, mice produce different types of USV, which are not indicators of
positive or negative affective states but likely function to facilitate or inhibit social interactions [112].
As such, male mice emit USV mainly during mating behaviors (in the presence of females or their
pheromones), i.e., 70 kHz “pre-mating” USV, which help to coordinate the mating process, and 40 kHz
“mating” USV [113,114]. Female mice, on the other hand, emit USV when alone, searching for pups or
in the presence of other females [115]. Rat and mouse pups emit so called “distress-calls” when they
are separated from their mother. These USV have frequencies of 40 kHz (rat pups) and 70–100 kHz
(mouse pups) and are thought to reflect a negative affective state [112].
3.1. Genetic Models of Impaired NMDA Receptor Functioning; Effects on Social Communication
Altered social communication has been described in genetically modified mice that show deficits
in social behavior (Table 1). As such, male NR1(neo-/-) mice that express only 5% of normal levels
of the essential NMDA receptor GluN1 subunit show deficits in social interaction [35–37] and fewer
“pre-mating” 70 kHz USV during mating behavior [116]. Similarly, knock-out mice with loss of
GluN1 subunit in parvalbumin-containing GABAergic interneurons during development, which show
reduced social motivation and impaired social interaction [38,39], also show reduced “pre-mating”
70 kHz USV [38]. Reduced social communication through USV was also described in autistic Shank2
knock-out mice, which show decreased function of the GluN2A- and GluN2B-containing NMDA
receptors in the hippocampus and impaired social interaction [96]. When allowed to interact with a
receptive female, male Shank2 knock-out mice emitted less frequently USV and had a longer latency to
make the first call [96]. Serine racemase knock-out mice, which show impaired social investigation and
an impaired NMDA receptor function due to a 90% reduction in cortical D-serine [45], also emit fewer
USV in the presence of a conspecific [44].
3.2. Effects of the NMDA Receptor Antagonists and Agonists on Social Communication
In rats, diminished social interaction is typically associated with a lower amount of 50 kHz USV [117].
Accordingly, pharmacological manipulations that impair social interaction in rats (see Section 2.2) were
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shown to reduce 50 kHz USV (Table 2). Boulay et al. [118] observed a decrease in 50 kHz USV in rats exposed
to human tickling after an acute PCP injection. Similarly, 2-ethylamino-2-thiophen-2-yl-cyclohexan-1-one
(tiletamine, an un-competitive NMDA receptor antagonist) and ketamine reduced social interaction and
accompanying 50 kHz USV in rats after acute administration [70]. Altered social communication was also
described in rats prenatally exposed to the anticonvulsant drug valproic acid, which is known to induce
an autistic-like phenotype [97,98]. Interestingly, acute administration of D-cycloserine, a partial agonist
of the glycine-binding site of the NMDA receptors, reversed the valproic acid-induced deficits in social
interaction and reduced the changes in USV [97]. Moskal et al. [119] described a rat line selectively bred
for high and low rates of rough-and-tumble play-induced 50 kHz USV. Low line rats show lower social
interaction, lower rates of play-induced pro-social 50 kHz USV and an increased proportion of monotonous
USV compared with randomly bred rats. While 50 kHz USV were associated with pro-social positive
affective states [120], monotonous USV were associated with communication deficits [121–123]. GLYX-13,
a partial agonist of the glycine-binding site of the NMDA receptors, increased rates of play-induced
pro-social USV and decreased the proportion of monotonous USV, indicating that GLYX-13 can reverse
the social communication deficit in low line rats by activating the NMDA receptors [80,119].
Reduced social communication was also described in rat and mice pups treated with several types of
NMDA receptor antagonists. As such, separation-induced USV in rat pups were reduced by competitive
antagonists (which block the glutamate-binding site), such as D,L-amino-phosphonovaleric acid (AP5),
2-amino-7-phosphonoheptanoic acid (AP7), 3-((+/-)-2-carboxypiperazin-4-yl)-propyl-1-phosphonic
acid (CPP) and MDL 100,453 [124–126], by un-competitive antagonists (which block the ion channel
by binding to a site within it), such as MK-801 [125] and by glycine antagonists (which block the
glycine-binding site), such as 5,7-dichlorokynurenic acid (5,7-DCKA) [125]. Administration of NMDA
was effective in both increasing USV by almost 50% and in reversing the effects of AP7 [124]. Interestingly,
Takahashi et al. [127] reported that the separation-induced USV in mouse pups are differently affected
by high versus low affinity un-competitive antagonists. As such, the high affinity antagonist MK-801
dose-dependently reduced USV, whereas the low affinity NMDA receptor antagonists memantine and
neramexane showed biphasic effects and enhanced USV at low to moderate doses. How MK-801 and
memantine/neramexane differently modulate USV is yet unclear and needs further investigation, but
might relate to different receptor binding kinetics and affinities of these antagonists. High affinity
MK-801 has very slow kinetics, whereas low affinity memantine is voltage-dependent and has quick
blocking and unblocking kinetics [128,129], which might be due to their diverse binding affinity to
different NMDA receptor subtypes [130,131].
4. Role of the NMDA Receptors in Social Memory
Individual recognition in socially living species is essential for the development of normal social
relationships and for the establishment of hierarchies that function to limit aggressive interactions and
to allow group living [132,133]. In most mammals, social recognition is achieved through information
encoded by olfactory and pheromonal signals [134]. The assessment of social memory in rodents
is based on their tendency to investigate unfamiliar conspecifics more intensely than familiar ones.
Intact social memory is, therefore, indicated by a reduced investigation of previously encountered
conspecifics [135] in the social recognition test or in the social discrimination test.
4.1. Genetic Models of Impaired NMDA Receptor Functioning; Effects on Social Memory
Several studies using genetically modified mice demonstrated the importance of NMDA
receptor-mediated neurotransmission in the regulation of social memory in rodents (Table 1). As such,
GluN2D knock-out mice with deficient expression of the GluN2D subunit of the NMDA receptors
exhibited a decreased preference for social novelty, despite normal olfactory function and social
interaction [136]. These GluN2D knock-out mice also showed a reduction in the complexity of dendritic
trees in the accessory olfactory bulb, suggesting a deficit in pheromone-processing pathway activation
which modulates social recognition memory [136]. By using forebrain-specific GluN2A overexpressing
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mice and forebrain-specific GluN2B overexpressing mice, Jacobs et al. [137] could demonstrate that
postnatal overexpression of the GluN2A subunit of the NMDA receptors impairs social memory,
while overexpression of the GluN2B subunit enhances social memory, i.e., prolongs recognition of
juveniles and females of the same strain. Furthermore, forebrain-specific GluN2B overexpressing
mice showed prolonged recognition of mice of a different strain and rodents of another species [138].
Deficits in social recognition memory were also described in mice in which the GluN1 subunit was
selectively eliminated in 40%–50% of cortical and hippocampal GABAergic interneurons during
postnatal development, but not during adulthood, suggesting that early postnatal inhibition of the
NMDA receptor activity in corticolimbic GABAergic interneurons contributes to the development
of social memory deficits [33]. However, Jacobs and Tsien [41] demonstrated that forebrain-specific
GluN1-containing NMDA receptors modulate social motivation and social recognition independent of
neuronal development. As such, an impaired social memory was observed in adult mice with inducible
forebrain-specific deletion of GluN1 subunits prior to behavioral testing [41]. Interestingly, Chiang
et al. [139] showed that deletion of the GluN1 subunit gene in the ventral, but not in the dorsal, CA3
pyramidal cells leads to deficits in social memory, while mice lacking the same gene in the DG granule
cells showed intact social memory. These results suggest that ventral hippocampal CA3 pyramidal cell
plasticity and transmission contribute to the encoding of social stimuli [139].
4.2. Effects of the NMDA Receptor Antagonists and Agonists on Social Memory
Pharmacological studies in rats and mice also revealed deficits in social memory after
administration of NMDA receptor antagonists, such as MK-801 [101,140–143], PCP [63,144,145] and
ketamine [146] (Table 2). Conversely, enhancement of the NMDA receptor function by targeting
either the glutamate-binding site with NMDA [147] or the glycine-binding site was shown to enhance
social recognition memory in rodents. As such, D-serine, a full agonist of the glycine-binding site
of the NMDA receptors, was shown to prolong social memory in rats [140] and to improve the
MK-801-induced deficits in social memory [143]. Pyrroloquinoline quinone (PQQ), a powerful
neuroprotectant that specifically binds to the glycine-binding site of the brain NMDA receptors, also
improved the MK-801-induced deficits in social memory and even accentuated the effects of D-serine
when administered in combination [143]. Inhibition of glycine transporter 1 with the GlyT1-inhibitors
N[3-(4′-flurophenyl)-3-(4′-phenylphenoxy) propyl]sarcosine (NFPS) and 3-chloro-N-{(S)-[3-(1-
ethyl-1H-pyrazol-4-yl)phenyl][(2S)-piperidin-2-yl]methyl}-4-(trifluoromethyl)pyridine-2-carboxamide
(TASP0315003), which increase the NMDA receptor function by indirectly activating the glycine-binding
site, was shown to enhance social recognition in treatment-naïve rats and to prevent the MK-801-induced
deficits in social memory [101,140]. Similarly, SSR-504734 and SSR130800, other GlyT1-inhibitors,
improved the social recognition deficits induced by neonatal PCP treatment in rats [63,144]. SSR130800
was shown to reversibly block glycine uptake in mouse brain cortical homogenates, to increase
extracellular levels of glycine in the rat prefrontal cortex and to potentiate NMDA-mediated excitatory
postsynaptic currents in rat hippocampal slices [144].
5. Role of the NMDA Receptors in Inter-Male Aggression
The occurrence of inter-male aggression in rodents is usually related to territorial defensive
behaviors or to the establishment and maintenance of the social status within a group [148]. The
aggressive behavior of rodents can be assessed in a resident–intruder paradigm, where an unfamiliar
male (intruder) is placed in the home cage of the experimental rodent (resident), which defends its
territory and shows aggressive behavior towards the intruder [149,150]. Higher levels of aggression
might be obtained when residents are co-housed with females before the test.
Several studies using genetically modified mice and pharmacological approaches investigated the
role of NMDA receptor-mediated neurotransmission in the regulation of inter-male aggression in rodents
(Tables 1 and 2). As such, mice expressing only 5% of normal levels of the essential NMDA receptor
GluN1 subunit (NR1(neo-/-) mice) show less aggressive behaviors in a social interaction paradigm [37],
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reduced social investigation towards a male intruder mouse and reduced inter-male aggression in a
resident-intruder paradigm [35,36], suggesting that the GluN1-containing NMDA receptors promote
territorial aggressive behavior. The involvement of the GluN2-containing NMDA receptors in aggressive
behavior seems to be more complex as it necessitates a fine-tuned balance of GluN2B expression in
the brain. As such, mice lacking ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2, an
enzyme with important function in neuroplasticity [151], show decreased NMDA receptor currents
and a decreased expression of GluN2B, but not of GluN1 and GluN2A, in the lateral amygdala [152].
These St8sia2 knock-out mice show an abnormal aggressive behavior, characterized by an increased
number of bites in vulnerable body parts, i.e., throat and belly, and an increased number of bites
while the male intruder is already submissive. St8sia2 knock-out mice also show high levels of
aggressiveness in a neutral arena against juvenile and female mice, a situation which usually does
not trigger aggressive responses in wild-type mice [152]. D-cycloserine, a partial agonist of the
glycine-binding site of the NMDA receptors, reversibly increased the NMDA receptor currents in both
wild-type and St8sia2 knock-out mice and normalized the abnormal aggressive behavior in St8sia2
knock-out mice [152]. D-cycloserine also increased affiliative behavior in wild-type mice, i.e., increased
social investigation and decreased aggression in resident mice [153]. Interestingly, both high- and
low-affinity un-competitive antagonists were shown to decrease aggressive behavior in mice. As such,
the high-affinity antagonists MK-801 and ketamine decreased bite frequency in resident mice [154]
and reduced the number of attacks in socially-isolated mice [155]. However, although social isolation
was shown to increase inter-male aggressive behavior in rats and mice [156–158], it increased GluN2A
and GluN2B expression in the hippocampus [159], suggesting that the decrease in the NMDA receptor
currents induced by MK-801 and ketamine normalizes inter-male aggressive behavior. Similarly, the
low-affinity NMDA receptor antagonists memantine and 1-amino-1,3,3,5,5-pentamethyl-cyclohexan
hydrochloride (MRZ 2/579) reduced morphine withdrawal-facilitated aggression in mice [160], without
affecting inter-male aggressive behavior in morphine-naïve mice [160,161]. Similarly to social isolation,
morphine withdrawal was shown to increase inter-male aggressive behavior [162–165] and to increase
the GluN2A and GluN2B expression in the frontal cortex and the GluN2B expression in the striatum [166].
It is, therefore, not surprising that the NMDA receptor antagonists reduced aggressive behavior in
individuals with increased GluN2A and GluN2B expression in the brain. These results suggest that
deviations in GluN2B- and possibly GluN2A-containing NMDA receptor function in either direction
leads to abnormal inter-male aggressive behavior and that correcting this deviation has beneficial effects.
6. Role of the NMDA Receptors in Sexual Behavior
Male sexual behavior consists of a pattern of genital and somato-motor responses which are
induced and maintained by pheromonal, hormonal and neural signals. It includes copulation and
pre-copulatory behaviors that allow males to detect a female and facilitate a receptive response [167].
The copulatory behavior consists of mounts, intromissions and ejaculations and can be assessed
by exposing males to receptive females [167]. Parameters such as mount latency and intromission
latency are indicative of sexual motivation, whereas the latency to ejaculation, the number of mounts
and intromissions before ejaculation and the time from ejaculation to the next intromission (i.e.,
post-ejaculation interval) are measures of sexual performance [167].
Most of the studies investigated the role of the GluN1-containing NMDA receptors in sexual
behavior (Tables 1 and 2). As such, NR1(neo-/-) mice, which express only 5% of normal levels of
the essential NMDA receptor GluN1 subunit and have a normal function of reproductive organs,
did not copulate with receptive wild-type females and failed to produce litters even after extended
breeding [35]. This abnormal sexual behavior seems to be facilitated by the impaired sociability of
male NR1(neo-/-) mice [35–37], as treatment with clozapine, which increased social approach and
reduced social withdrawal in mice [168], also increased copulatory behavior up to 30% of normal
levels seen in wild-type males [35]. A decreased breeding efficiency was also reported in mice in which
the GluN1 subunit was selectively eliminated in 40%–50% of cortical and hippocampal GABAergic
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interneurons in early postnatal development [40]. These mice showed a decreased copulatory
behavior, which was not the result of reproductive organ dysfunctions, as pairs that successfully bred
produced normal-sized litters. These two studies suggest that impaired GluN1-containing NMDA
receptor-mediated neurotransmission induces deficits in copulatory behavior which might be facilitated
by the accompanying deficits in social interaction.
Several studies have shown that both systemic and intra-medial preoptic area (MPOA) injections
of the un-competitive NMDA receptor antagonist MK-801 impaired sexual behavior in male and
female rats [169–171]. As such, systemic administration of MK-801 impaired copulatory behavior
in sexually naïve and sexually experienced male rats [171] and impaired female sexual behavior in
rats [172]. Injections of MK-801 into the MPOA, a brain region essential for the expression of male
sexual behavior [173], impaired copulatory behavior in sexually naïve and sexually experienced
rats [169,170], i.e., decreased the numbers of mounts, intromissions and ejaculations and increased the
latencies for these measures. Dominguez et al. [169] demonstrated that almost all MPOA neurons that
were activated, i.e., expressed c-Fos, following mating contained the GluN1 subunit of the NMDA
receptors and that mating increased phosphorylation (activation) of GluN1 in the MPOA. They could
also show that blockade of the NMDA receptors by MK-801 in the MPOA decreased mating-induced
c-Fos expression and phosphorylation of NMDA receptors and impaired male sexual behavior [169].
These results demonstrate that mating activates the GluN1-containing NMDA receptors in the MPOA
and that this activation is important for the expression of male sexual behavior.
7. Role of the NMDA Receptors in Maternal Behavior
Maternal behavior consists of a group of behaviors exhibited by the mother that promotes the survival
of the offspring and includes maternal care and maternal aggression [174]. Maternal care refers to the
nurturing of the offspring and includes behaviors such as nest building, retrieval of pups and crouching
over pups, whereas maternal aggression has the function of protecting the pups and the nest [174,175].
There are only a few studies investigating the role of NMDA receptor-mediated neurotransmission
in maternal behavior (Tables 1 and 2). As such, impaired pup retrieval, as an indicator of impaired
maternal care, was described in autistic Shank2 knock-out mice, which show impaired sociability
and a decreased GluN2A- and GluN2B-containing NMDA receptor function in the hippocampus [96].
Severe deficits in maternal behavior were also observed in Hbegf knock-out mice [176], which have a
genetic deletion of the heparin-binding epidermal growth factor-like growth factor (HB-EGF). These
mice show reduced expression of hippocampal GluN1/GluN2-NMDA receptor subunits and reduced
expression of PSD-95, a scaffold protein involved in the NMDA receptor aggregation in the CNS [177].
The impaired maternal behavior of Hbegf knock-out mice was reflected by a lack of nest building,
impaired pup retrieval and lack of nursing (lactation behavior), which resulted in a delayed pup
growth and decreased pup survival [176].
Muroi and Ishii [178] demonstrated that administration of AP5, a competitive NMDA receptor
antagonist, in the dorsal raphe nucleus, a brain region that regulates both maternal care and maternal
aggression [179,180], inhibited maternal aggression, but not maternal care. In contrast, injections of
NMDA into the dorsal raphe nucleus impaired maternal care, i.e., pup retrieval, pup licking and
crouching over the pups, suggesting that glutamatergic inputs to the dorsal raphe nucleus regulate the
preferential display of maternal care over maternal aggression [178]. Interestingly, the un-competitive
NMDA receptor antagonist MK-801 blocked experienced-based facilitation of maternal care [181].
As such, when unexperienced mothers were administered MK-801 before the first contact with the
pups, they showed no maternal care, i.e., couching over the pups and licking the pups, when tested
10 days later. However, when MK-801 was administered following one hour of contact with the
pups, the females showed unaltered maternal care at a later time-point, suggesting that the NMDA
receptor-mediated neurotransmission is required for the long-term experienced-based facilitation of
maternal care [181].
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Table 1. Expression of NMDA receptors in animal models with impaired social behavior.
Species NMDA Receptor Functioning Behavioral Deficit References
NR1(neo-/-) mice Expression of GluN1 only to 5% of normal levels
Impaired social interaction
Impaired social communication
Reduced inter-male aggression
Impaired sexual behavior
[35–37]
[116]
[35–37]
[35]
PV-selective NR1 knock-out mice Loss of GluN1 subunit in parvalbumin-containing GABAergic interneurons during development Impaired social interactionImpaired social communication
[38,39]
[38]
Ppp1r2-cre+/−; NR1loxP/loxP mice Selective elimination of GluN1 in 40%–50% of cortical and hippocampal GABAergic interneurons in earlypostnatal development, but not in the post-adolescent period
Impaired social interaction
Impaired social memory
Impaired sexual behavior
[40]
iFB knock-out mice Inducible forebrain-specific deletion of GluN1 subunits Impaired social interactionImpaired social memory [41]
CA3 NR1 knock-out mice Deletion of the GluN1 subunit gene in the ventral, but not the dorsal, CA3 pyramidal cells Impaired social memory [139]
DG NR1 knock-out mice Deletion of the GluN1 subunit gene in DG granule cells Normal social memory [139]
GluN2B2A(CTD) mice Increased postnatal forebrain expression of the GluN2A subunit Impaired social memory [137]
GluN2A2B(CTD) mice Increased postnatal forebrain expression of the GluN2B subunit Enhanced social memory [137,138]
GluN2D knock-out mice Deficient expression of the GluN2D subunit Normal social interactionImpaired social memory [136]
Grin1D481N mice
Chronic and developmentally diminished NMDA receptor glycine site occupancy (fivefold decrease in
NMDA receptor glycine affinity) Impaired social interaction [42,43]
Serine racemase knock-out mice Impaired NMDA receptor function due to a 90% reduction in cortical D-serine Impaired social interactionImpaired social communication [44]
Hbegf knock-out mice Reduced expression of hippocampal GluN1/GluN2-NMDA receptor subunitsReduced expression of PSD-95, a scaffold protein involved in the NMDA receptor aggregation in the CNS Impaired maternal behavior [176,177]
Shank2 knock-out mice Decreased function of the GluN2A- and GluN2B-containing NMDA receptors in the hippocampus
Impaired social interaction
Impaired social communication
Impaired maternal behavior
[96]
St8sia2 knock-out mice Decreased NMDA receptor currents and decreased expression of GluN2B, but not of GluN1 and GluN2A, inthe lateral amygdala
Abnormal (psychopathological)
aggressive behavior [152]
Socially-isolated mice and rats Increased GluN2A and GluN2B expression in the hippocampusIncreased GluN2A expression in the prefrontal cortex
Impaired social interaction
Altered social communication
Impaired social memory
Increased inter-male aggression
Impaired sexual behavior
[182,183]
[184]
[185]
[156–159]
[186–188]
Mice during morphine
withdrawal
Increased GluN2A and GluN2B expression in the frontal cortex
Increased GluN2B expression in the striatum Increased inter-male aggression [162–166]
NMDA, N-methyl-D-aspartate; NR1, GluN1 subunit; PV, parvalbumin; GABA, gamma aminobutyric acid; iFB, inducible forebrain-specific expression; CA3, cornu ammonis 3; DG, dentate
gyrus; NR2, GluN2 subunit.
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Table 2. Effects of the NMDA receptor agonists and antagonists on social behavior in rodents.
Action Drug Species Behavioral Change References
Effects on social interaction
Un-competitive NMDA receptor antagonists
MK-801
PCP
Ketamine
Mice and rats Decreased social interaction
[46–55]
[56–66]
[67–73]
NMDA receptor antagonist Memantine IRSp53 knock-out micePrenatally citalopram-treated mice
Reduced social interaction deficits [74,75]
GluN2A-preferring antagonist PEAQX Rats Decreased social interaction [4,49]
GluN2B-preferring antagonist Ifenprodil Rats Decreased social interaction [49]
Full agonist of the glycine-binding site D-serine
Autistic Balb/c mice
Grin1D481N mice
Postnatally polyI:C-treated mice
Reduced social interaction deficits [89][90]
[91]
Partial agonist of the glycine-binding site D-cycloserine
Autistic Balb/c mice
Autistic BTBR T+tf/J mice
Autistic Shank2 knock-out mice
Prenatally VPA-treated mice
Postnatally PCP-treated mice
Reduced social interaction deficits
[85,92–94]
[95]
[96]
[98]
[99]
GlyT1 inhibitor TASP0315003VU0410120
Postnatally PCP-treated mice
Autistic Balb/c mice Reduced social interaction deficits
[101]
[102]
Social communication (USV)
Un-competitive NMDA receptor antagonists
PCP
Tiletamine
Ketamine
Rats Reduced 50 kHz USV
[118]
[70]
[70]
Un-competitive NMDA receptor antagonist MK-801 Rat pups Reduced separation-induced USV [125,127]
Competitive NMDA receptor antagonists
AP5
AP7
CPP
MDL 100,453
Rat pups Reduced separation-induced USV [124,126]
NMDA receptor antagonists MemantineNeramexane Rat pups
Increased separation-induced USV at low to moderate
doses and reduced separation-induced USV at high doses [127]
Glycine antagonist 5,7-DCKA Rat pups Reduced separation-induced USV [125]
NMDA receptor agonist NMDA Rat pups Increased separation-induced USV [124]
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Table 2. Cont.
Action Drug Species Behavioral Change References
Partial agonist of the glycine-binding site D-cycloserineGLYX-13
Prenatally VPA-treated rats
Rats selectively bred for low rates of play-induced
50 kHz USV
Reduced deficits in social communication
Reversed deficits in social communication
[97]
[80,119]
Social memory
Un-competitive NMDA receptor antagonists
MK-801
PCP
Ketamine
Rats and mice Impaired social memory [101,140–143][63,144–146]
Full agonists of the glycine-binding site D-serinePQQ
Rats
MK-801-treated rats
Enhanced social memory
Improved social memory deficits
[140]
[143]
GlyT1 inhibitors
NFPS
TASP0315003
SSR-504734
SSR130800
Rats
MK-801-treated rats
Neonatally PCP-treated rats
Enhanced social memory
Improved social memory deficits
[140]
[101]
[63]
[144]
Inter-male aggression
Un-competitive NMDA receptor antagonists MK-801Ketamine Socially-isolated mice Decreased inter-male aggression
[155]
[154]
NMDA receptor antagonists MemantineMRZ 2/579 Naïve and morphine-treated mice
Reduced morphine withdrawal-facilitated aggression, but
did not affect inter-male aggression in naïve mice
[160,161]
[160,161]
Partial agonist of the glycine-binding site D-cycloserine MiceSt8sia2 knock-out mice
Decreased inter-male aggression
Normalized the abnormal aggressive behavior
[153]
[152]
Sexual behavior
Un-competitive NMDA receptor antagonist MK-801 Male and female rats Impaired sexual behavior [169–172]
Maternal behavior
Un-competitive NMDA receptor antagonist MK-801 Rats Blocked experienced-based facilitation of maternal care [181]
Competitive NMDA receptor antagonist AP5 Mice Impaired maternal aggression, but not maternal care [178]
NMDA receptor agonist NMDA Mice Impaired maternal care [178]
NMDA, N-methyl-D-aspartate; MK-801, 5R,10S-(+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine hydrogen maleate; MK-801, dizocilpine, 5R,10S-(+)-5-methyl-
10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine hydrogen maleate; PCP, phencyclidine; memantine, 1-amino-3,5-dimethyladamantane hydrochloride; PEAQX, {NVP-AAM o77;
P-[[[(15)-1-(4-Bromophenyl)ethyl]amino](1,2,3,4-tetrahydro-2,3-dioxo-5-qyuinoxalinyl)methyl]phosphoric acid tetrasodium salt}; polyI:C, polyriboinosinic-polyribocytidilic acid; VPA, valproic
acid; GlyT1, glycine transporter 1; TASP0315003, 3-chloro-N-{(S)-[3-(1-ethyl-1H-pyrazol-4-yl)phenyl][(2S)-piperidin- 2-yl]methyl}-4-(trifluoromethyl)pyridine-2-carboxamide; VU0410120,
2,4-dichloro-N-((4-(cyclopropylmethyl)-1-(ethyl sulfonyl)piperidin-4-yl)methyl)benzamide; USV, ultrasonic vocalizations; tiletamine, 2-ethylamino-2-thiophen-2-yl-cyclohexan-1-one; AP5,
D,L-amino-phosphonovaleric acid; AP7, 2-amino-7-phosphonoheptanoic acid; CPP, 3-((+/-)-2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid; memantine, 1-amino-3,5-dimethyladamantane
hydrochloride; 5,7-DCKA, 5,7-dichlorokynurenic acid; PQQ, pyrroloquinoline quinone; NFPS, N[3-(4′-flurophenyl)-3-(4′-phenylphenoxy) propyl]sarcosine; MRZ 2/579, 1-amino-
1,3,3,5,5-pentamethyl-cyclohexan hydrochloride.
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8. Conclusions
Recent discoveries from genetically modified mice and pharmacological studies using NMDA
receptor antagonists link the impaired function of the NMDA receptors to abnormal social behavior,
such as impaired social interaction and communication, deficits in social memory, deficits in sexual and
maternal behavior, as well as abnormal or heightened aggression. Pharmacological stimulation of the
glycine-binding site, either by direct stimulation or by elevating the synaptic glycine levels, represents a
promising strategy for the normalization of genetically-induced, pharmacologically-induced or innate
deficits in social behavior. This accumulating evidence and the identification of new subunit-selective
NMDA receptor modulators make further studies investigating their potentially beneficial role
worthwhile. Apart from providing a better understanding of the neural mechanisms involved and
regulated by different NMDA receptor subunits, these investigations might stimulate the development
of selective tools for the improved treatment of psychiatric disorders associated with social deficits.
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